• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟疾的流行病学、耐药性及病理生理学

Epidemiology, drug resistance, and pathophysiology of malaria.

作者信息

Dayananda Kiran K, Achur Rajeshwara N, Gowda D Channe

机构信息

Department of Biochemistry, K.S. Hegde Medical Academy, NITTE University, Mangaluru, Karnataka, India.

Department of Biochemistry, Kuvempu University, Shankaraghatta, Karnataka, India.

出版信息

J Vector Borne Dis. 2018 Jan-Mar;55(1):1-8. doi: 10.4103/0972-9062.234620.

DOI:10.4103/0972-9062.234620
PMID:29916441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6996296/
Abstract

Malaria, caused by the protozoan parasites of the genus Plasmodium, is a major health problem in many countries of the world. Five parasite species namely, Plasmodium falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi, cause malaria in humans. Of these, P. falciparum and P. vivax are the most prevalent and account for the majority of the global malaria cases. In most areas of Africa, P. vivax infection is essentially absent because of the inherited lack of Duffy antigen receptor for chemokines on the surface of red blood cells that is involved in the parasite invasion of erythrocytes. Therefore, in Africa, most malaria infections are by P. falciparum and the highest burden of P. vivax infection is in Southeast Asia and South America. Plasmodium falciparum is the most virulent and as such, it is responsible for the majority of malarial mortality, particularly in Africa. Although, P. vivax infection has long been considered to be benign, recent studies have reported life-threatening consequences, including acute respiratory distress syndrome, cerebral malaria, multi-organ failure, dyserythropoiesis and anaemia. Despite exhibiting low parasite biomass in infected people due to parasite's specificity to infect only reticulocytes, P. vivax infection triggers higher inflammatory responses and exacerbated clinical symptoms than P. falciparum, such as fever and chills. Another characteristic feature of P. vivax infection, compared to P. falciparum infection, is persistence of the parasite as dormant liver-stage hypnozoites, causing recurrent episodes of malaria. This review article summarizes the published information on P. vivax epidemiology, drug resistance and pathophysiology.

摘要

疟疾由疟原虫属的原生动物寄生虫引起,是世界上许多国家的主要健康问题。有五种寄生虫物种,即恶性疟原虫、间日疟原虫、三日疟原虫、卵形疟原虫和诺氏疟原虫可导致人类疟疾。其中,恶性疟原虫和间日疟原虫最为普遍,占全球疟疾病例的大多数。在非洲的大多数地区,由于红细胞表面缺乏参与寄生虫侵入红细胞的趋化因子达菲抗原受体,基本不存在间日疟原虫感染。因此,在非洲,大多数疟疾感染是由恶性疟原虫引起的,间日疟原虫感染的最高负担在东南亚和南美洲。恶性疟原虫毒性最强,因此它是导致大多数疟疾死亡的原因,尤其是在非洲。尽管长期以来间日疟原虫感染被认为是良性的,但最近的研究报告了危及生命的后果,包括急性呼吸窘迫综合征、脑型疟疾、多器官衰竭、红细胞生成异常和贫血。尽管由于寄生虫仅感染网织红细胞的特异性,感染人群中的寄生虫生物量较低,但与恶性疟原虫相比,间日疟原虫感染引发的炎症反应更高,临床症状更严重,如发热和寒战。与恶性疟原虫感染相比,间日疟原虫感染的另一个特征是寄生虫以休眠的肝期潜隐子形式持续存在,导致疟疾反复发作。这篇综述文章总结了已发表的关于间日疟原虫流行病学、耐药性和病理生理学的信息。

相似文献

1
Epidemiology, drug resistance, and pathophysiology of malaria.疟疾的流行病学、耐药性及病理生理学
J Vector Borne Dis. 2018 Jan-Mar;55(1):1-8. doi: 10.4103/0972-9062.234620.
2
UK malaria treatment guidelines.英国疟疾治疗指南。
J Infect. 2007 Feb;54(2):111-21. doi: 10.1016/j.jinf.2006.12.003. Epub 2007 Jan 9.
3
Clinical implications of a gradual dormancy concept in malaria.疟疾中逐渐休眠概念的临床意义
Parasitol Res. 2016 Jun;115(6):2139-48. doi: 10.1007/s00436-016-5043-0. Epub 2016 Apr 15.
4
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.间日疟原虫,一种被忽视的人类疟原虫,在知识方面存在关键空白。
Lancet Infect Dis. 2009 Sep;9(9):555-66. doi: 10.1016/S1473-3099(09)70177-X.
5
Effects of Plasmodium vivax malaria in pregnancy.间日疟原虫疟疾在孕期的影响。
Lancet. 1999 Aug 14;354(9178):546-9. doi: 10.1016/s0140-6736(98)09247-2.
6
[Role of primaquine in malaria control and elimination in French-speaking Africa].[伯氨喹在非洲法语区疟疾控制与消除中的作用]
Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17.
7
An insight on drug resistance in Plasmodium vivax, a still neglected human malaria parasite.关于间日疟原虫(一种仍被忽视的人类疟原虫)耐药性的深入了解。
Ann Ist Super Sanita. 2020 Oct-Dec;56(4):409-418. doi: 10.4415/ANN_20_04_02.
8
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.在间日疟原虫和恶性疟原虫多重耐药感染流行地区的不良妊娠结局。
Clin Infect Dis. 2008 May 1;46(9):1374-81. doi: 10.1086/586743.
9
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
10
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.间日疟原虫疟疾的新进展:重症疾病与氯喹耐药性的上升
Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1.

引用本文的文献

1
Evolution of tandem repeats in putative circumsporozoite protein to enhance its function: A recent and exclusive event in in India.假定环子孢子蛋白中串联重复序列的进化以增强其功能:印度近期发生的独特事件。
Curr Res Microb Sci. 2025 Jun 27;9:100432. doi: 10.1016/j.crmicr.2025.100432. eCollection 2025.
2
Genetic characterization of linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study.利用Illumina AmpliSeq技术对与美国本地疟疾传播相关因素的基因特征分析(2023年):一项基因流行病学研究
Lancet Reg Health Am. 2025 Jun 21;48:101159. doi: 10.1016/j.lana.2025.101159. eCollection 2025 Aug.
3
A Systematic Review and Meta-Analysis of MIP-1α and MIP-1β Chemokines in Malaria in Relation to Disease Severity.MIP-1α和MIP-1β趋化因子与疟疾疾病严重程度关系的系统评价和荟萃分析
Medicina (Kaunas). 2025 Apr 6;61(4):676. doi: 10.3390/medicina61040676.
4
A systematic review and meta-analysis of blood level of MCP-1/CCL-2 in severe and uncomplicated malaria.一项关于严重疟疾和非复杂性疟疾患者血液中 MCP-1/CCL-2 水平的系统评价和荟萃分析。
Sci Rep. 2024 Nov 20;14(1):28738. doi: 10.1038/s41598-024-80201-y.
5
Chloroquine-primaquine therapeutic response and safety in patients with uncomplicated Plasmodium vivax malaria in the Colombian Amazon region.在哥伦比亚亚马逊地区无并发症间日疟原虫感染患者中氯喹-伯氨喹治疗反应和安全性。
Malar J. 2024 Nov 18;23(1):348. doi: 10.1186/s12936-024-05170-z.
6
Plasmodium Vivax in a Healthy, Young Immigrant Male.一名健康年轻男性移民体内的间日疟原虫
Cureus. 2024 Jul 30;16(7):e65743. doi: 10.7759/cureus.65743. eCollection 2024 Jul.
7
Prospective study of malaria in pregnancy, placental and congenital malaria in Northwest Colombia.哥伦比亚西北部妊娠疟疾、胎盘疟疾和先天性疟疾的前瞻性研究。
Malar J. 2024 Apr 25;23(1):116. doi: 10.1186/s12936-024-04948-5.
8
Comparing malaria risk exposure in rural Cambodia population using GPS tracking and questionnaires.使用 GPS 追踪和问卷调查比较柬埔寨农村人口的疟疾风险暴露情况。
Malar J. 2024 Mar 12;23(1):75. doi: 10.1186/s12936-024-04890-6.
9
Functional characterization of hexose transporter 1.葡萄糖转运蛋白 1 的功能特征分析。
Front Cell Infect Microbiol. 2024 Jan 12;13:1321240. doi: 10.3389/fcimb.2023.1321240. eCollection 2023.
10
Vivax malaria: a possible stumbling block for malaria elimination in India.间日疟:印度消除疟疾的一个潜在障碍。
Front Public Health. 2024 Jan 8;11:1228217. doi: 10.3389/fpubh.2023.1228217. eCollection 2023.

本文引用的文献

1
The hide and seek of Plasmodium vivax in West Africa: report from a large-scale study in Beninese asymptomatic subjects.间日疟原虫在西非的隐匿踪迹:来自贝宁无症状受试者大规模研究的报告
Malar J. 2016 Nov 25;15(1):570. doi: 10.1186/s12936-016-1620-z.
2
Diagnosis and Treatment of Plasmodium vivax Malaria.间日疟的诊断与治疗
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):35-51. doi: 10.4269/ajtmh.16-0171. Epub 2016 Oct 5.
3
Global Epidemiology of Plasmodium vivax.间日疟原虫的全球流行病学
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):15-34. doi: 10.4269/ajtmh.16-0141. Epub 2016 Jul 11.
4
Malaria eradication and elimination: views on how to translate a vision into reality.疟疾根除与消除:关于如何将愿景转化为现实的观点。
BMC Med. 2015 Jul 25;13:167. doi: 10.1186/s12916-015-0384-6.
5
Reduced polymorphism in the Kelch propeller domain in Plasmodium vivax isolates from Cambodia.柬埔寨间日疟原虫分离株中 Kelch 螺旋桨结构域的多态性降低。
Antimicrob Agents Chemother. 2015 Jan;59(1):730-3. doi: 10.1128/AAC.03908-14. Epub 2014 Nov 10.
6
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
7
Geographical variation in Plasmodium vivax relapse.间日疟原虫复发的地理差异。
Malar J. 2014 Apr 15;13:144. doi: 10.1186/1475-2875-13-144.
8
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.青蒿素耐药恶性疟原虫的一个分子标记。
Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.
9
Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan.巴基斯坦南部地区间日疟原虫对磺胺多辛-乙胺嘧啶耐药相关突变的流行情况。
Malar J. 2013 Jul 26;12:261. doi: 10.1186/1475-2875-12-261.
10
Placental histopathological changes associated with Plasmodium vivax infection during pregnancy.妊娠期间与间日疟原虫感染相关的胎盘组织病理学变化。
PLoS Negl Trop Dis. 2013;7(2):e2071. doi: 10.1371/journal.pntd.0002071. Epub 2013 Feb 14.